Figure 2.

Overall survival (a) and recurrence-free survival (b) in the more number group patients with low CA19-9 level and high CA19-9 level.

Overall survival (a) and recurrence-free survival (b) in the more number group patients with low CA19-9 level and high CA19-9 level.